A detailed history of Avanza Fonder Ab transactions in Boston Scientific Corp stock. As of the latest transaction made, Avanza Fonder Ab holds 161,371 shares of BSX stock, worth $15.8 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
161,371
Holding current value
$15.8 Million
% of portfolio
0.43%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

BUY
$83.62 - $91.5 $13.5 Million - $14.8 Million
161,371 New
161,371 $14.4 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Avanza Fonder Ab Portfolio

Follow Avanza Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avanza Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Avanza Fonder Ab with notifications on news.